Im fully aware that end P2 is where (provide this does what we think and hope) the real value of the company will be , I'm also aware that this is the ASX and people are impatient , and price appreciation comes on the expectation of news, company values on the asx have a direct relationship to boredom
Ann: Phase 2 Stroke Clinical Trial Update, page-28
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.015(2.01%) |
Mkt cap ! $97.99M | |||
| Open | High | Low | Value | Volume |
| 75.5¢ | 77.0¢ | 74.0¢ | $80.55K | 107.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1624 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.0¢ | 7000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |